Skip to main content

Advertisement

SpringerLink
Log in

Liver transplantation for hepatitis C

  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

Hepatitis C virus (HCV) infection is the leading cause of endstage liver disease in Western and Asian countries. However, after liver transplantation, HCV recurs in virtually all patients, and estimated HCV-related graft cirrhosis at 5-year follow-up is 30%. Although immunosuppression accounts for a major part of the accelerated progression of HCV in the transplant population, the best immunosuppression for recipients with HCV that could avoid such complication remains unknown at present. Combination therapy of interferon and ribavirin is thought to be the most effective for the treatment or prophylaxis of HCV infection. However, who should be treated, when treatment should be initiated, and with what agent should patients with HCV infection be treated are still unknown. The current data on HCV recurrence in patients who have received either living- or deceased-donor liver transplantation are controversial, but they are, presumably, similar. Thus, to avoid HCV recurrence in living-donor liver transplantation, we have to take approaches similar to those used for patients receiving deceased-donor liver transplantation. Based on reports from major transplant centers around the world, we consider the best strategy for liver transplantation-related HCV infection is steroid-free immunosuppression and preemptive low-dose interferon and ribavirin combination therapy. Here we describe our experience with living-donor liver transplantion for patients with hepatitis C at Osaka University. There is a need for standardizing the treatment for HCV infection. This can only be achieved through collaborative work between various liver transplant centers worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47:1–39

    Google Scholar 

  2. MJ Alter D Kruszon-Moran OV Nainan GM McQuillan F Gao LA Moyer et al. (1999) ArticleTitleThe prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 556–62 Occurrence Handle10451460 Occurrence Handle1:STN:280:DyaK1Mzmt1Whsw%3D%3D Occurrence Handle10.1056/NEJM199908193410802

    Article  PubMed  CAS  Google Scholar 

  3. H Yoshizawa (2002) ArticleTitleHepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future Oncology 62 IssueIDSuppl 1 8–17 Occurrence Handle11868791 Occurrence Handle10.1159/000048270

    Article  PubMed  Google Scholar 

  4. InstitutionalAuthorNameThe Japanese Liver Transplantation Society (2004) ArticleTitleLiver transplantation in Japan. Registry by the Japanese Liver Transplantation Society Jpn J Transplant 39 634–42

    Google Scholar 

  5. EJ Gane BC Portmann NV Naoumov HM Smith JA Underhill PT Donaldson et al. (1996) ArticleTitleLong-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 815–20 Occurrence Handle8596547 Occurrence Handle1:STN:280:BymC2snislA%3D Occurrence Handle10.1056/NEJM199603283341302

    Article  PubMed  CAS  Google Scholar 

  6. LM Forman JD Lewis JA Berlin HI Feldman MR Lucey (2002) ArticleTitleThe association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 889–96 Occurrence Handle11910340 Occurrence Handle10.1053/gast.2002.32418

    Article  PubMed  Google Scholar 

  7. M Berenguer FX Lopez-Labrador TL Wright (2001) ArticleTitleHepatitis C and liver transplantation J Hepatol 35 666–78 Occurrence Handle11690716 Occurrence Handle1:STN:280:DC%2BD3MnktVyguw%3D%3D Occurrence Handle10.1016/S0168-8278(01)00179-9

    Article  PubMed  CAS  Google Scholar 

  8. P Martin RW Busuttil RM Goldstein JS Crippin GB Klintmalm WE Fitzsimmons et al. (2004) ArticleTitleImpact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial Liver Transpl 10 1258–62 Occurrence Handle15376310 Occurrence Handle10.1002/lt.20222

    Article  PubMed  Google Scholar 

  9. M Prieto M Berenguer JM Rayon J Cordoba L Arguello D Carrasco et al. (1999) ArticleTitleHigh incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes Hepatology 29 250–6 Occurrence Handle9862874 Occurrence Handle1:STN:280:DyaK1M%2FotFOjtg%3D%3D Occurrence Handle10.1002/hep.510290122

    Article  PubMed  CAS  Google Scholar 

  10. M Berenguer M Prieto JM Rayon J Mora M Pastor V Ortiz et al. (2000) ArticleTitleNatural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation Hepatology 32 852–8 Occurrence Handle11003634 Occurrence Handle1:STN:280:DC%2BD3cvpsFKltA%3D%3D Occurrence Handle10.1053/jhep.2000.17924

    Article  PubMed  CAS  Google Scholar 

  11. UP Neumann T Berg M Bahra G Puhl O Guckelberger JM Langrehr et al. (2004) ArticleTitleLong-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 77 226–31 Occurrence Handle14742986 Occurrence Handle10.1097/01.TP.0000101738.27552.9D

    Article  PubMed  Google Scholar 

  12. G Testa JS Crippin GJ Netto RM Goldstein LW Jennings BS Brkic et al. (2000) ArticleTitleLiver transplantation for hepatitis C: recurrence and disease progression in 300 patients Liver Transpl 6 553–61 Occurrence Handle10980053 Occurrence Handle1:STN:280:DC%2BD3cvpsVOhsw%3D%3D Occurrence Handle10.1053/jlts.2000.9741

    Article  PubMed  CAS  Google Scholar 

  13. M Berenguer J Crippin R Gish N Bass A Bostrom G Netto et al. (2003) ArticleTitleA model to predict severe HCV-related disease following liver transplantation Hepatology 38 34–41 Occurrence Handle12829984 Occurrence Handle10.1053/jhep.2003.50278

    Article  PubMed  Google Scholar 

  14. JR Lake JS Shorr BJ Steffen AH Chu RD Gordon RH Wiesner (2005) ArticleTitleDifferential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis Am J Transplant 5 549–57 Occurrence Handle15707410 Occurrence Handle10.1111/j.1600-6143.2005.00741.x

    Article  PubMed  Google Scholar 

  15. EJ Gane NV Naoumov KP Qian MU Mondelli G Maertens BC Portmann et al. (1996) ArticleTitleA longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 167–77 Occurrence Handle8536853 Occurrence Handle1:STN:280:BymC387gtVA%3D Occurrence Handle10.1053/gast.1996.v110.pm8536853

    Article  PubMed  CAS  Google Scholar 

  16. M Berenguer M Prieto F San Juan JM Rayon F Martinez D Carrasco et al. (2002) ArticleTitleContribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 202–10 Occurrence Handle12085366 Occurrence Handle10.1053/jhep.2002.33993

    Article  PubMed  Google Scholar 

  17. SL Condron MA Heneghan K Patel A Dev JG McHutchison AJ Muir (2005) ArticleTitleEffect of donor age on survival of liver transplant recipients with hepatitis C virus infection Transplantation 80 145–8 Occurrence Handle16003247 Occurrence Handle10.1097/01.TP.0000164291.35925.7A

    Article  PubMed  Google Scholar 

  18. DN Samonakis CK Triantos U Thalheimer A Quaglia G Leandro R Teixeira et al. (2005) ArticleTitleImmunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation Liver Transpl 11 386–95 Occurrence Handle15776454 Occurrence Handle10.1002/lt.20344

    Article  PubMed  Google Scholar 

  19. KW Burak Kremers Wk KP Batts RH Wiesner CB Rosen RR Razonable et al. (2002) ArticleTitleImpact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C Liver Transpl 8 362–9 Occurrence Handle11965581 Occurrence Handle10.1053/jlts.2002.32282

    Article  PubMed  Google Scholar 

  20. M Berenguer (2002) ArticleTitleNatural history of recurrent hepatitis C Liver Transpl 8 S14–8 Occurrence Handle12362293 Occurrence Handle10.1053/jlts.2002.35781

    Article  PubMed  Google Scholar 

  21. M Berenguer JM Rayon M Prieto V Aguilera D Nicolas V Ortiz et al. (2001) ArticleTitleAre posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 7 790–6 Occurrence Handle11552213 Occurrence Handle1:STN:280:DC%2BD3MrgtlWnsg%3D%3D Occurrence Handle10.1053/jlts.2001.23794

    Article  PubMed  CAS  Google Scholar 

  22. R Sreekumar A Gonzalez-Koch Y Maor-Kendler K Batts L Moreno-Luna J Poterucha et al. (2000) ArticleTitleEarly identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation Hepatology 32 1125–30 Occurrence Handle11050065 Occurrence Handle1:STN:280:DC%2BD3M%2FivFaguw%3D%3D Occurrence Handle10.1053/jhep.2000.19340

    Article  PubMed  CAS  Google Scholar 

  23. M Charlton E Seaberg R Wiesner J Everhart R Zetterman J Lake et al. (1998) ArticleTitlePredictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 823–30 Occurrence Handle9731579 Occurrence Handle1:STN:280:DyaK1cvgtVejtw%3D%3D Occurrence Handle10.1002/hep.510280333

    Article  PubMed  CAS  Google Scholar 

  24. O Chazouilleres M Kim C Combs L Ferrell P Bacchetti J Roberts et al. (1994) ArticleTitleQuantitation of hepatitis C virus RNA in liver transplant recipients Gastroenterology 106 994–9 Occurrence Handle8144005 Occurrence Handle1:STN:280:ByuC1M3pslE%3D

    PubMed  CAS  Google Scholar 

  25. GL Davis DR Nelson N Terrault TL Pruett TD Schiano CV Fletcher et al. (2005) ArticleTitleA randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients Liver Transpl 11 941–9 Occurrence Handle16035063 Occurrence Handle10.1002/lt.20405

    Article  PubMed  Google Scholar 

  26. JS McMillan T Shaw PW Angus SA Locarnini (1995) ArticleTitleEffect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro Hepatology 22 36–43 Occurrence Handle7601429 Occurrence Handle1:CAS:528:DyaK2MXntFSjtrw%3D Occurrence Handle10.1016/0270-9139(95)90350-X

    Article  PubMed  CAS  Google Scholar 

  27. N Magy B Cribier C Schmitt B Ellero D Jaeck K Boudjema et al. (1999) ArticleTitleEffects of corticosteroids on HCV infection Int J Immunopharmacol 21 253–61 Occurrence Handle10408633 Occurrence Handle1:CAS:528:DyaK1MXjvF2msro%3D Occurrence Handle10.1016/S0192-0561(99)00005-3

    Article  PubMed  CAS  Google Scholar 

  28. M Garcia-Retortillo X Forns A Feliu E Moitinho J Costa M Navasa et al. (2002) ArticleTitleHepatitis C virus kinetics during and immediately after liver transplantation Hepatology 35 680–7 Occurrence Handle11870384 Occurrence Handle10.1053/jhep.2002.31773

    Article  PubMed  Google Scholar 

  29. M Charlton E Seaberg (1999) ArticleTitleImpact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Liver Transpl Surg 5 S107–14 Occurrence Handle10431024 Occurrence Handle1:STN:280:DyaK1Mzmt1ynuw%3D%3D Occurrence Handle10.1002/lt.500050203

    Article  PubMed  CAS  Google Scholar 

  30. JI Herrero A de la Pena J Quiroga B Sangro N Garcia I Sola et al. (1998) ArticleTitleRisk factors for recurrence of hepatitis C after liver transplantation Liver Transpl Surg 4 265–70 Occurrence Handle9649638 Occurrence Handle1:STN:280:DyaK1czhsFakuw%3D%3D Occurrence Handle10.1002/lt.500040406

    Article  PubMed  CAS  Google Scholar 

  31. M Berenguer M Prieto J Cordoba JM Rayon D Carrasco V Olaso et al. (1998) ArticleTitleEarly development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection J Hepatol 28 756–63 Occurrence Handle9625309 Occurrence Handle1:CAS:528:DyaK1cXmvVWltLo%3D Occurrence Handle10.1016/S0168-8278(98)80224-9

    Article  PubMed  CAS  Google Scholar 

  32. HR Rosen DR Gretch M Oehlke KD Flora KG Benner JM Rabkin et al. (1998) ArticleTitleTiming and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury Transplantation 65 1178–82 Occurrence Handle9603164 Occurrence Handle1:STN:280:DyaK1c3msVejsQ%3D%3D Occurrence Handle10.1097/00007890-199805150-00006

    Article  PubMed  CAS  Google Scholar 

  33. GV Papatheodoridis D Patch GM Dusheiko AK Burroughs (1999) ArticleTitleThe outcome of hepatitis C virus infection after liver transplantation — is it influenced by the type of immunosuppression? J Hepatol 30 731–8 Occurrence Handle10207819 Occurrence Handle1:STN:280:DyaK1M3isVahtA%3D%3D Occurrence Handle10.1016/S0168-8278(99)80208-6

    Article  PubMed  CAS  Google Scholar 

  34. R Reding J Gras E Sokal JB Otte HF Davies (2003) ArticleTitleSteroid-free liver transplantation in children Lancet 362 2068–70 Occurrence Handle14697809 Occurrence Handle1:CAS:528:DC%2BD3sXpvFylsLY%3D Occurrence Handle10.1016/S0140-6736(03)15104-5

    Article  PubMed  CAS  Google Scholar 

  35. S Marubashi K Dono K Amano N Hama K Gotoh H Takahashi et al. (2005) ArticleTitleSteroid-free living donor liver transplantation in adults Transplantation 80 704–6 Occurrence Handle16177648 Occurrence Handle1:CAS:528:DC%2BD2MXhtVajs7bJ Occurrence Handle10.1097/01.tp.0000172187.28376.3b

    Article  PubMed  CAS  Google Scholar 

  36. JD Eason S Nair AJ Cohen JL Blazek GE Loss SuffixJr (2003) ArticleTitleSteroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy Transplantation 75 1396–9 Occurrence Handle12717237 Occurrence Handle1:CAS:528:DC%2BD3sXjt1alt7w%3D Occurrence Handle10.1097/01.TP.0000062834.30922.FE

    Article  PubMed  CAS  Google Scholar 

  37. F Filipponi F Callea M Salizzoni GL Grazi LR Fassati M Rossi et al. (2004) ArticleTitleDouble-blind comparison of hepatitis C histological recurrence rate in HCV+ liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine Transplantation 78 1488–95 Occurrence Handle15599313 Occurrence Handle1:CAS:528:DC%2BD2MXjvV2qug%3D%3D Occurrence Handle10.1097/01.TP.0000140881.07208.4E

    Article  PubMed  CAS  Google Scholar 

  38. S Brillanti M Vivarelli N De Ruvo AA Aden V Camaggi A D'Errico et al. (2002) ArticleTitleSlowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation Liver Transpl 8 884–8 Occurrence Handle12360428 Occurrence Handle10.1053/jlts.2002.34640

    Article  PubMed  Google Scholar 

  39. K Watashi M Hijikata M Hosaka M Yamaji K Shimotohno (2003) ArticleTitleCyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes Hepatology 38 1282–8 Occurrence Handle14578868 Occurrence Handle1:CAS:528:DC%2BD3sXpsVOnt7o%3D Occurrence Handle10.1053/jhep.2003.50449

    Article  PubMed  CAS  Google Scholar 

  40. K Watashi N Ishii M Hijikata D Inoue T Murata Y Miyanari et al. (2005) ArticleTitleCyclophilin B is a functional regulator of hepatitis C virus RNA polymerase Mol Cell 19 111–22 Occurrence Handle15989969 Occurrence Handle1:CAS:528:DC%2BD2MXmsVejtrg%3D Occurrence Handle10.1016/j.molcel.2005.05.014

    Article  PubMed  CAS  Google Scholar 

  41. AM Di Bisceglie J McHutchison CM Rice (2002) ArticleTitleNew therapeutic strategies for hepatitis C Hepatology 35 224–31 Occurrence Handle11786980 Occurrence Handle10.1053/jhep.2002.30531

    Article  PubMed  Google Scholar 

  42. A Jain R Kashyap AJ Demetris B Eghstesad R Pokharna JJ Fung (2002) ArticleTitleA prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C Liver Transpl 8 40–6 Occurrence Handle11799484 Occurrence Handle10.1053/jlts.2002.29763

    Article  PubMed  Google Scholar 

  43. R Wiesner J Rabkin G Klintmalm S McDiarmid A Langnas J Punch et al. (2001) ArticleTitleA randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients Liver Transpl 7 442–50 Occurrence Handle11349266 Occurrence Handle1:STN:280:DC%2BD3MzhslWgsg%3D%3D Occurrence Handle10.1053/jlts.2001.23356

    Article  PubMed  CAS  Google Scholar 

  44. RH Wiesner JS Shorr BJ Steffen AH Chu RD Gordon JR Lake (2005) ArticleTitleMycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C Liver Transpl 11 750–9 Occurrence Handle15973716 Occurrence Handle10.1002/lt.20453

    Article  PubMed  Google Scholar 

  45. PA Sheiner ME Schwartz E Mor LK Schluger N Theise K Kishikawa et al. (1995) ArticleTitleSevere or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation Hepatology 21 30–4 Occurrence Handle7806166 Occurrence Handle1:STN:280:ByqC3cvnslA%3D Occurrence Handle10.1016/0270-9139(95)90404-2

    Article  PubMed  CAS  Google Scholar 

  46. DR Nelson C Soldevila-Pico A Reed MF Abdelmalek AW Hemming WJ Van der Werf et al. (2001) ArticleTitleAnti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation Liver Transpl 7 1064–70 Occurrence Handle11753908 Occurrence Handle1:STN:280:DC%2BD38%2Fgtl2ntQ%3D%3D Occurrence Handle10.1053/jlts.2001.29414

    Article  PubMed  CAS  Google Scholar 

  47. T Kato H Yoshida K Sadfar E Martinez S Nishida J Moon et al. (2005) ArticleTitleSteroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study Transplant Proc 37 1217–9 Occurrence Handle15848674 Occurrence Handle1:CAS:528:DC%2BD2MXjsFKisbY%3D Occurrence Handle10.1016/j.transproceed.2004.12.042

    Article  PubMed  CAS  Google Scholar 

  48. RM Thomas JJ Brems G Guzman-Hartman S Yong P Cavaliere DH Van Thiel (2003) ArticleTitleInfection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation Liver Transpl 9 905–15 Occurrence Handle12942451 Occurrence Handle10.1053/jlts.2003.50166

    Article  PubMed  Google Scholar 

  49. GT Everson J Trotter L Forman M Kugelmas A Halprin B Fey et al. (2005) ArticleTitleTreatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy Hepatology 42 255–62 Occurrence Handle16025497 Occurrence Handle1:CAS:528:DC%2BD2MXpt1eksrc%3D Occurrence Handle10.1002/hep.20793

    Article  PubMed  CAS  Google Scholar 

  50. N Singh T Gayowski CF Wannstedt AO Shakil MM Wagener JJ Fung et al. (1998) ArticleTitleInterferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial Transplantation 65 82–6 Occurrence Handle9448149 Occurrence Handle1:CAS:528:DyaK1cXnsFaitg%3D%3D Occurrence Handle10.1097/00007890-199801150-00016

    Article  PubMed  CAS  Google Scholar 

  51. PA Sheiner P Boros FM Klion SN Thung LK Schluger JY Lau et al. (1998) ArticleTitleThe efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation Hepatology 28 831–8 Occurrence Handle9731580 Occurrence Handle1:CAS:528:DyaK1cXlvVyitbw%3D Occurrence Handle10.1002/hep.510280334

    Article  PubMed  CAS  Google Scholar 

  52. V Mazzaferro A Tagger M Schiavo E Regalia A Pulvirenti ML Ribero et al. (2001) ArticleTitlePrevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment Transplant Proc 33 1355–7 Occurrence Handle11267325 Occurrence Handle1:CAS:528:DC%2BD3MXitV2nu7Y%3D Occurrence Handle10.1016/S0041-1345(00)02508-2

    Article  PubMed  CAS  Google Scholar 

  53. Y Sugawara M Makuuchi Y Matsui Y Kishi N Akamatsu J Kaneko et al. (2004) ArticleTitlePreemptive therapy for hepatitis C virus after living-donor liver transplantation Transplantation 78 1308–11 Occurrence Handle15548968 Occurrence Handle1:CAS:528:DC%2BD2cXpvVGmtLg%3D Occurrence Handle10.1097/01.TP.0000142677.12473.E5

    Article  PubMed  CAS  Google Scholar 

  54. AK Shergill M Khalili S Straley K Bollinger JP Roberts NA Ascher et al. (2005) ArticleTitleApplicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation Am J Transplant 5 118–24 Occurrence Handle15636619 Occurrence Handle10.1111/j.1600-6143.2004.00648.x

    Article  PubMed  Google Scholar 

  55. T Bizollon P Pradat JY Mabrut M Chevallier M Adham S Radenne et al. (2005) ArticleTitleBenefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C Am J Transplant 5 1909–13 Occurrence Handle15996238 Occurrence Handle10.1111/j.1600-6143.2005.00976.x

    Article  PubMed  Google Scholar 

  56. MF Abdelmalek RJ Firpi C Soldevila-Pico AI Reed AW Hemming C Liu et al. (2004) ArticleTitleSustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C Liver Transpl 10 199–207 Occurrence Handle14762857 Occurrence Handle10.1002/lt.20074

    Article  PubMed  Google Scholar 

  57. D Samuel T Bizollon C Feray B Roche SN Ahmed C Lemonnier et al. (2003) ArticleTitleInterferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 642–50 Occurrence Handle12612903 Occurrence Handle1:CAS:528:DC%2BD3sXisVKntr8%3D Occurrence Handle10.1053/gast.2003.50095

    Article  PubMed  CAS  Google Scholar 

  58. RT Stavitz ML Shiffman AJ Sanyal VA Luketic RK Sterling DM Heuman et al. (2004) ArticleTitleEffects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation Liver Transpl 10 850–8 Occurrence Handle10.1002/lt.20189

    Article  Google Scholar 

  59. S Saab D Kalmaz NA Gajjar J Hiatt F Durazo S Han et al. (2004) ArticleTitleOutcomes of acute rejection after interferon therapy in liver transplant recipients Liver Transpl 10 859–67 Occurrence Handle15237369 Occurrence Handle10.1002/lt.20157

    Article  PubMed  Google Scholar 

  60. L Castells V Vargas H Allende I Bilbao J Luis Lazaro C Margarit et al. (2005) ArticleTitleCombined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation J Hepatol 43 53–9 Occurrence Handle15876467 Occurrence Handle1:CAS:528:DC%2BD2MXlt1GhsLo%3D Occurrence Handle10.1016/j.jhep.2005.02.015

    Article  PubMed  CAS  Google Scholar 

  61. J Dumortier JY Scoazec P Chevallier O Boillot (2004) ArticleTitleTreatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 669–74 Occurrence Handle15030984 Occurrence Handle1:CAS:528:DC%2BD2cXitFKhsLY%3D Occurrence Handle10.1016/j.jhep.2003.12.015

    Article  PubMed  CAS  Google Scholar 

  62. PJ Gaglio S Malireddy BS Levitt D Lapointe-Rudow J Lefkowitch M Kinkhabwala et al. (2003) ArticleTitleIncreased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors Liver Transpl 9 1028–35 Occurrence Handle14526396 Occurrence Handle10.1053/jlts.2003.50211

    Article  PubMed  Google Scholar 

  63. GT Everson J Trotter (2003) ArticleTitleRole of adult living donor liver transplantation in patients with hepatitis C Liver Transpl 9 S64–8 Occurrence Handle14528432 Occurrence Handle10.1053/jlts.2003.50224

    Article  PubMed  Google Scholar 

  64. MA Zimmerman JF Trotter (2003) ArticleTitleLiving donor liver transplantation in patients with hepatitis C Liver Transpl 9 S52–7 Occurrence Handle14586896 Occurrence Handle10.1053/jlts.2003.50256

    Article  PubMed  Google Scholar 

  65. H Van Vlierberghe R Troisi I Colle S Ricciardi M Praet B de Hemptinne (2004) ArticleTitleHepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults Transplantation 77 210–4 Occurrence Handle14742983 Occurrence Handle1:STN:280:DC%2BD2c%2FmsVamsA%3D%3D Occurrence Handle10.1097/01.TP.0000101007.59478.8B

    Article  PubMed  CAS  Google Scholar 

  66. M Garcia-Retortillo X Forns JM Llovet M Navasa A Feliu A Massaguer et al. (2004) ArticleTitleHepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation Hepatology 40 699–707 Occurrence Handle15349910 Occurrence Handle10.1002/hep.20357

    Article  PubMed  Google Scholar 

  67. ML Shiffman RT Stravitz MJ Contos AS Mills RK Sterling VA Luketic et al. (2004) ArticleTitleHistologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation Liver Transpl 10 1248–55 Occurrence Handle15376308 Occurrence Handle10.1002/lt.20232

    Article  PubMed  Google Scholar 

  68. G Tisone M Angelico G Palmieri F Pisani L Baiocchi G Vennarecci et al. (1998) ArticleTitleImmunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study Transpl Int 11 IssueIDSuppl 1 S267–9 Occurrence Handle9664993 Occurrence Handle10.1007/s001470050475

    Article  PubMed  Google Scholar 

  69. JD Eason GE Loss J Blazek S Nair AL Mason (2001) ArticleTitleSteroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial Liver Transpl 7 693–7 Occurrence Handle11510013 Occurrence Handle1:STN:280:DC%2BD3MvmsVOksg%3D%3D Occurrence Handle10.1053/jlts.2001.26353

    Article  PubMed  CAS  Google Scholar 

  70. F Filipponi M Salizzoni G Grazi R Pisati R Ferrara (2001) ArticleTitleStudy of simulect-based, steroid-free immunosuppressive regimen in HCV+ de novo liver transplant patients: preliminary results Transplant Proc 33 3211–2 Occurrence Handle11750378 Occurrence Handle1:CAS:528:DC%2BD3MXpt1aksLc%3D Occurrence Handle10.1016/S0041-1345(01)02367-3

    Article  PubMed  CAS  Google Scholar 

  71. JD Eason J Blazek A Mason S Nair GE Loss (2001) ArticleTitleSteroid-free immunosuppression through thymoglobulin induction in liver transplantation Transplant Proc 33 1470–1 Occurrence Handle11267378 Occurrence Handle1:STN:280:DC%2BD3M7mvV2hug%3D%3D Occurrence Handle10.1016/S0041-1345(00)02556-2

    Article  PubMed  CAS  Google Scholar 

  72. B Ringe F Braun E Schutz L Fuzesi T Lorf R Canelo et al. (2001) ArticleTitleA novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil Transplantation 71 508–15 Occurrence Handle11258429 Occurrence Handle1:CAS:528:DC%2BD3MXitlSitL0%3D Occurrence Handle10.1097/00007890-200102270-00005

    Article  PubMed  CAS  Google Scholar 

  73. Figueras J, et al. Liver Transpl 2002;8(6):C-34(Abs.134)

  74. JM Langrehr UP Neumann M Lang AR Muller S Jonas U Settmacher et al. (2002) ArticleTitleFirst results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV Transplant Proc 34 1565–6 Occurrence Handle12176487 Occurrence Handle1:CAS:528:DC%2BD38XmtlKitrs%3D Occurrence Handle10.1016/S0041-1345(02)03024-5

    Article  PubMed  CAS  Google Scholar 

  75. J Pirenne R Aerts T Koshiba F Van Gelder T Roskams M Schetz et al. (2003) ArticleTitleSteroid-free immunosuppression during and after liver transplantation — a 3-yr follow-up report Clin Transplant 17 177–82 Occurrence Handle12780665 Occurrence Handle10.1034/j.1399-0012.2003.00017.x

    Article  PubMed  Google Scholar 

  76. MM Allikan PY Kwo OW Cummings LJ Born NK Boyle MB Schenk et al. (1997) ArticleTitleEffect of tacrolimus or cyclosporine immunosuppression on the occurrence of severe HCV hepatitis in post-transplant patients Hepatology 26 156A

    Google Scholar 

  77. XA Zervos D Weppler GP Fragulidis MB Torres JR Nery MF Khan et al. (1998) ArticleTitleComparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation Transplantation 65 1044–6 Occurrence Handle9583863 Occurrence Handle1:CAS:528:DyaK1cXjt1yqurg%3D Occurrence Handle10.1097/00007890-199804270-00006

    Article  PubMed  CAS  Google Scholar 

  78. P Martin RM Goldstein J Goss P Seu LL Goldstein R Strobling et al. (1998) ArticleTitleA prospective controlled trial of tacrolimus vs. cyclosporine on orthotopic liver transplant recipients with hepatitis C virus: Lack of effect on recurrent hepatitis Hepatology 28 313A Occurrence Handle10.1002/hep.510280536

    Article  Google Scholar 

  79. GA Smallwood T Wallace JM DePaolo LA Harris AC Stieber TG Bover et al. (1999) ArticleTitleProgression of hepatitis C following liver transplant: relationship to immunosuppression Transplantation 67 S15 Occurrence Handle10.1097/00007890-199904150-00062

    Article  Google Scholar 

  80. A Edo E Murio JL Lazaro R Charco I Bilbao L Pou et al. (1999) ArticleTitleOral administration of tacrolimus (FK506) as primary immunosuppression in liver transplantation: a comparative study with conventional cyclosporine Transplantology 10 11–7

    Google Scholar 

  81. I Bilbao L Pou E Allende JL Lazaro R Charco E Hidalgo et al. (2001) ArticleTitleComparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation Transplant Proc 33 2124–6 Occurrence Handle11377472 Occurrence Handle1:CAS:528:DC%2BD3MXjsleqs7w%3D Occurrence Handle10.1016/S0041-1345(01)01969-8

    Article  PubMed  CAS  Google Scholar 

  82. JM Rabkin CL Corless HR Rosen AJ Olyaei (2001) ArticleTitlePharmaco-economic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation Transplant Proc 33 1532–4 Occurrence Handle11267411 Occurrence Handle1:CAS:528:DC%2BD3MXitV2ms7s%3D Occurrence Handle10.1016/S0041-1345(00)02585-9

    Article  PubMed  CAS  Google Scholar 

  83. SW Paik HP Tan AS Klein JK Boitnott PJ Thuluvath (2002) ArticleTitleOutcome of orthotopic liver transplantation in patients with hepatitis C Dig Dis Sci 47 450–5 Occurrence Handle11855567 Occurrence Handle10.1023/A:1013759230800

    Article  PubMed  Google Scholar 

  84. TL Wright C Combs M Kim L Ferrell P Bacchetti N Ascher et al. (1994) ArticleTitleInterferon-alpha therapy for hepatitis C virus infection after liver transplantation Hepatology 20 773–9 Occurrence Handle7927216 Occurrence Handle1:STN:280:ByqD3M3gvFQ%3D Occurrence Handle10.1016/0270-9139(94)90750-1

    Article  PubMed  CAS  Google Scholar 

  85. V Vargas R Charco L Castells R Esteban C Margarit (1995) ArticleTitleAlpha-interferon for acute hepatitis C in liver transplant patients Transplant Proc 27 1222–3 Occurrence Handle7533374 Occurrence Handle1:STN:280:ByqC1cvksFE%3D

    PubMed  CAS  Google Scholar 

  86. C Feray D Samuel M Gigou V Paradis MF David C Lemonnier et al. (1995) ArticleTitleAn open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection Hepatology 22 1084–9 Occurrence Handle7557855 Occurrence Handle1:CAS:528:DyaK2MXptl2js7o%3D Occurrence Handle10.1016/0270-9139(95)90613-4

    Article  PubMed  CAS  Google Scholar 

  87. EJ Gane CJ Tibbs JK Ramage BC Portmann R Williams (1995) ArticleTitleRibavirin therapy for hepatitis C infection following liver transplantation Transpl Int 8 61–4 Occurrence Handle7534082 Occurrence Handle1:CAS:528:DyaK2sXisVajug%3D%3D Occurrence Handle10.1007/BF00366714

    Article  PubMed  CAS  Google Scholar 

  88. N Singh T Gayowski CF Wannstedt IR Marino MM Wagener (1996) ArticleTitleInterferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy Clin Transplant 10 348–51 Occurrence Handle8884107 Occurrence Handle1:STN:280:ByiD3sflt1I%3D

    PubMed  CAS  Google Scholar 

  89. MS Cattral M Krajden IR Wanless M Rezig R Cameron PD Greig et al. (1996) ArticleTitleA pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation Transplantation 61 1483–8 Occurrence Handle8633376 Occurrence Handle1:CAS:528:DyaK28Xkt1Smurw%3D Occurrence Handle10.1097/00007890-199605270-00013

    Article  PubMed  CAS  Google Scholar 

  90. T Bizollon U Palazzo C Ducerf M Chevallier M Elliott J Baulieux M Pouyet et al. (1997) ArticleTitlePilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation Hepatology 26 500–4 Occurrence Handle9252166 Occurrence Handle1:CAS:528:DyaK2sXlsVWjurc%3D Occurrence Handle10.1002/hep.510260236

    Article  PubMed  CAS  Google Scholar 

  91. TA Kizilisik M al-Sebayel A Hammad I Al-Traif CG Ramirez A Abdulla (1997) ArticleTitleHepatitis C recurrence in liver transplant recipients Transplant Proc 29 2875–7 Occurrence Handle9365599 Occurrence Handle1:STN:280:DyaK1c%2Fjt1ejsQ%3D%3D Occurrence Handle10.1016/S0041-1345(97)00715-X

    Article  PubMed  CAS  Google Scholar 

  92. EJ Gane SK Lo SM Riordan BC Portmann JY Lau NV Naoumov et al. (1998) ArticleTitleA randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation Hepatology 27 1403–7 Occurrence Handle9581698 Occurrence Handle1:CAS:528:DyaK1cXjtVSjt7c%3D Occurrence Handle10.1002/hep.510270530

    Article  PubMed  CAS  Google Scholar 

  93. MS Cattral AW Hemming IR Wanless H Al Ashgar M Krajden L Lilly et al. (1999) ArticleTitleOutcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation Transplantation 67 1277–80 Occurrence Handle10342322 Occurrence Handle1:CAS:528:DyaK1MXjsleku7s%3D Occurrence Handle10.1097/00007890-199905150-00014

    Article  PubMed  CAS  Google Scholar 

  94. SJ Cotler DR Ganger S Kaur H Rosenblate S Jakate DG Sullivan et al. (2001) ArticleTitleDaily interferon therapy for hepatitis C virus infection in liver transplant recipients Transplantation 71 261–6 Occurrence Handle11213071 Occurrence Handle1:CAS:528:DC%2BD3MXhtF2msr4%3D Occurrence Handle10.1097/00007890-200101270-00017

    Article  PubMed  CAS  Google Scholar 

  95. DV Gopal JM Rabkin BS Berk CL Corless S Chou A Olyaei et al. (2001) ArticleTitleTreatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin Liver Transpl 7 181–90 Occurrence Handle11244158 Occurrence Handle1:STN:280:DC%2BD3M3lvFOjug%3D%3D Occurrence Handle10.1053/jlts.2001.22447

    Article  PubMed  CAS  Google Scholar 

  96. J Ahmad SF Dodson AJ Demetris JJ Fung AO Shakil (2001) ArticleTitleRecurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin Liver Transpl 7 863–9 Occurrence Handle11679984 Occurrence Handle1:STN:280:DC%2BD3MrntVGhsA%3D%3D Occurrence Handle10.1053/jlts.2001.27869

    Article  PubMed  CAS  Google Scholar 

  97. AB Alberti LS Belli A Airoldi L de Carlis G Rondinara E Minola et al. (2001) ArticleTitleCombined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study Liver Transpl 7 870–6 Occurrence Handle11679985 Occurrence Handle1:STN:280:DC%2BD3MrntVGhsQ%3D%3D Occurrence Handle10.1053/jlts.2001.27871

    Article  PubMed  CAS  Google Scholar 

  98. ME De Vera GA Smallwood K Rosado L Davis E Martinez S Sharma et al. (2001) ArticleTitleInterferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation Transplantation 71 678–86 Occurrence Handle11292302 Occurrence Handle1:CAS:528:DC%2BD3MXivVGksLg%3D Occurrence Handle10.1097/00007890-200103150-00019

    Article  PubMed  CAS  Google Scholar 

  99. A Kornberg M Hommann A Tannapfel T Wagner T Grube U Schotte et al. (2001) ArticleTitleLong-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients Am J Transplant 1 350–5 Occurrence Handle12099379 Occurrence Handle1:CAS:528:DC%2BD38XisFartg%3D%3D Occurrence Handle10.1034/j.1600-6143.2001.10410.x

    Article  PubMed  CAS  Google Scholar 

  100. RJ Firpi MF Abdelmalek C Soldevila-Pico A Reed A Hemming R Howard et al. (2002) ArticleTitleCombination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C Liver Transpl 8 1000–6 Occurrence Handle12424712 Occurrence Handle10.1053/jlts.2002.34968

    Article  PubMed  Google Scholar 

  101. B Lavezzo A Franchello A Smedile E David A Barbui M Torrani et al. (2002) ArticleTitleTreatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin J Hepatol 37 247–52 Occurrence Handle12127430 Occurrence Handle1:CAS:528:DC%2BD38XlsVKjsrg%3D Occurrence Handle10.1016/S0168-8278(02)00109-5

    Article  PubMed  CAS  Google Scholar 

  102. H Rodriguez-Luna A Khatib P Sharma G De Petris JW Williams J Ortiz K Hansen et al. (2004) ArticleTitleTreatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series Transplantation 77 190–4 Occurrence Handle14742979 Occurrence Handle1:CAS:528:DC%2BD2cXmsFKmtg%3D%3D Occurrence Handle10.1097/01.TP.0000100481.14514.BB

    Article  PubMed  CAS  Google Scholar 

  103. J Dumortier JY Scoazec P Chevallier O Boillot (2004) ArticleTitleTreatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 669–74 Occurrence Handle15030984 Occurrence Handle1:CAS:528:DC%2BD2cXitFKhsLY%3D Occurrence Handle10.1016/j.jhep.2003.12.015

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan

    Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita & Morito Monden

Authors
  1. Shigeru Marubashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keizo Dono
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsushi Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yutaka Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroaki Nagano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Koji Umeshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Morito Monden
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Marubashi, S., Dono, K., Miyamoto, A. et al. Liver transplantation for hepatitis C. J Hepatobiliary Pancreat Surg 13, 382–392 (2006). https://doi.org/10.1007/s00534-005-1078-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-005-1078-9

Key words

Search

Navigation